PDSB
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- PDS Biotech to host a key opinion leader event on PDS0301 for advanced colorectal cancer with liver metastasesOct 6, 2026
- PDS Biotech announces JAMA Oncology publication of Phase 2 VERSATILE-002 results for PDS0101 plus pembrolizumab in HPV16-positive recurrent or metastatic head and neck cancerSep 22, 2026
- PDS Biotech announced a strategic refocus prioritizing PDS0301 in metastatic colorectal cancer and a partnership strategy for PDS0101Aug 11, 2026
- PDS Biotech adopted an amended protocol for the Phase 3 VERSATILE-003 trial, adding PFS as the primary endpoint for interim analysis and potential accelerated approvalFeb 20, 2026
- PDS Biotech presented preliminary Phase 2 results for PDS01ADC in prostate cancerJan 28, 2026